Jazz Pharmaceuticals plc — Director's Dealing 2024

Aug 7, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2024-08-02

Reporting Person: Cook Jennifer E. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-02	Ordinary Shares	A	3731	$0.0	Acquired	10619	Direct
2024-08-06	Ordinary Shares	F	1484	$111.35	Disposed	9135	Direct

Footnotes

F1: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 25, 2025.

F2: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.